This CEO is Using LSD To Fight Depression, PMS, and Other Mental Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio Therapeutics -CSE-$MBIO

This CEO is Using LSD To Fight Depression, PMS, and Other Mental
Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio
Therapeutics -CSE-MBIO





This CEO is Using LSD To Fight Depression, PMS, and Other Mental
Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio
Therapeutics -CSE-MBIO





Justin Hanka | Co-founder | Chief Executive Director


MindBio Therapeutics Ltd





Ticker: $MBIO – Canada.


Frankfurt Börse - FRA: WF6





Website:


https://www.mindbiotherapeutics.com/





Bio:


Justin works in investment banking and financing of mergers and
acquisitions and particularly he specializes in capital markets
transactions and working with technology in the life and health
sciences sector.





He is Non-Executive Director of EonX (CSE:EONX), a financial
technology company, Non-Executive Chairman of Blackhawk Growth
Corp (CSE:BLR), an investment issuer and Non-Executive Director
and Chairman of SPARC AI (CSE:SPAI), an engineering company
commercializing covert geospatial location and tracking
technology for drones.





Justin is Co-Founder and CEO of Hardenbrook Group, a merchant and
investment bank and Co-founder and CEO of MindBio Therapeutics
(CSE:MBIO), a clinical stage pharma developing psychedelic
microdosing formulations to treat depression and is currently
dosing in multiple Phase 2B clinical trials. Justin is also
Co-founder of Life AI Corp, a life sciences technology company
developing AI solutions for longevity and enhancing health and
wellness at scale.





Justin’s expertise and interests span the pharmaceutical and life
sciences sector, fin-techs, technology that utilizes AI and
machine learning methods, banking and insurance, health and
wellness, biohacking, anti-ageing and ecommerce.